1MK.F MAUNA KEA TECHNOL.EO -04
- Market cap
- EUR 16.5M
- P/E
- 0.5x
- P/B
- 135.58x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 1MK.F undervalued?
Graham number1MK.F trades 71.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MAUNA KEA TECHNOL.EO -04 fundamental analysis
No fundamental analysis for MAUNA KEA TECHNOL.EO -04 yet.
MAUNA KEA TECHNOL.EO -04 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MAUNA KEA TECHNOL.EO -04
Mauna Kea Technologies SA manufactures and sells medical devices in Europe, Middle East, Africa, the United States, Canada, and Asia. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables physicians to monitor disease progression over time, assess reactions as they occur, classify areas of uncertainty, and guide surgical procedures,…
Full company profileMAUNA KEA TECHNOL.EO -04 financial statements
MAUNA KEA TECHNOL.EO -04 annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 7.48M | 10.5M | 7.66M | 8.22M |
| Gross Profit | 5.40M | 8.37M | 6.40M | 6.27M |
| Operating Income | -897K | -5.69M | -6.05M | -5.20M |
| EBITDA | -9.93M | -1.46M | -7.97M | 12.9M |
| Net Income | -11.2M | -3.73M | -10.4M | 10.8M |
| EPS | -0.24 | -0.06 | -0.15 | 0.06 |
| Balance Sheet | ||||
| Total Assets | 19.8M | 22.9M | 16.2M | 13.4M |
| Total Liabilities | 39.7M | 40.2M | 40.6M | 18.2M |
| Shareholders' Equity | -19.9M | -17.3M | -24.4M | -4.82M |
| Cash & Short-term Investments | 3.14M | 7.87M | 1.92M | 4.97M |
| Cash Flow | ||||
| Operating Cash Flow | -8.83M | -753K | -6.32M | -3.68M |
| Capital Expenditure | 144K | 382K | 215K | 213K |
| Free Cash Flow | -8.97M | -1.14M | -6.54M | -3.89M |
| Ratios | ||||
| ROA | -56.5% | -16.2% | -64.0% | 80.4% |
| Net Profit Margin | -149.5% | -35.6% | -135.9% | 131.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
MAUNA KEA TECHNOL.EO -04 dividends
MAUNA KEA TECHNOL.EO -04 has not paid dividends in the last 5 fiscal years.
Who owns MAUNA KEA TECHNOL.EO -04
- Insiders 24.39%
- Institutions 14.50%
- Public & others 61.12%
- Shares outstanding 199M
- Free float 172M
MAUNA KEA TECHNOL.EO -04 company profile
- Company name
- MAUNA KEA TECHNOL.EO -04
- Ticker
- 1MK.F
- ISIN
- FR0010609263
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 56
- Fiscal year end
- December
- Address
- 9, rue d'Enghien, Paris, France, 75010
- Phone
- 33 1 48 24 03 45
- Website
- maunakeatech.com
About MAUNA KEA TECHNOL.EO -04
Mauna Kea Technologies SA manufactures and sells medical devices in Europe, Middle East, Africa, the United States, Canada, and Asia. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables physicians to monitor disease progression over time, assess reactions as they occur, classify areas of uncertainty, and guide surgical procedures, and help diagnose and treat patients. The company was incorporated in 2000 and is headquartered in Paris, France.
MAUNA KEA TECHNOL.EO -04 management
5- Mr. Alexandre Loiseau Ph.D.Co-Founder, CEO & Chairman
- Mr. Come de La Tour du PinChief Financial Officer
- Ms. Nathalie LecoqChief Operating Officer
- Mr. François Lacombe Ph.D.Chief Scientific Officer
- Mr. Daryl DonatelliPresident of U.S. & Head of Global Marketing